G protein-coupled receptor

5-HT2A receptor

5-hydroxytryptamine receptor 2A

The 5-HT2A receptor is one of the receptors for serotonin. It belongs to the G protein-coupled receptors, which have seven transmembrane domains and pass signals into the cell through G proteins. The human receptor was cloned from brain stem tissue, at the time under the name 5-HT2.1 Together with the 5-HT2B and 5-HT2C receptors it forms the 5-HT2 family. The three are similar in structure, pharmacology and signalling, and they are the only serotonin receptors that couple mainly to Gq.2,3

When an agonist binds, the receptor activates the G protein Gq. In the rat cortex, serotonin acting at this receptor stimulates the breakdown of membrane phosphoinositides.4,5 Gq activates phospholipase C, which forms inositol trisphosphate and diacylglycerol, mobilises calcium inside the cell and activates protein kinase C. The receptor also triggers arrestin signalling and the release of arachidonic acid. In many brain regions its activation excites neurons, probably by closing potassium channels. DOI, DOB, DOM and LSD behave as partial agonists in assays of the second messengers, and stimulation of the receptor changes the expression of several genes, among them the one for the neurotrophic factor BDNF.6,2,7 In cells that carry the human receptor, agonists cause a rapid rise in calcium inside the cell.8

The 5-HT2A receptor is the most abundant excitatory serotonin receptor in the brain, with the highest density in layer V of the cortex. It is also found in nearly every other tissue of the body to some degree.3 In the rat brain the mRNA of the receptor reaches high levels in only a few areas, among them the frontal cortex, the piriform cortex, the ventral and caudal part of area CA3, the medial mammillary nucleus, the pontine nuclei, the motor nuclei of the cranial nerves and the ventral horn of the spinal cord. It generally agrees with the distribution of the binding sites, although there are differences. The same study found no evidence of mRNA for the 5-HT2B receptor in the rat brain.9 In the cerebral cortex of the monkey and the rat, most cells that carry the receptor are pyramidal neurons. In the monkey the strongest labelling lies on their apical dendrites. Some interneurons carry the receptor too.10,11 Immunostaining, in situ hybridisation and autoradiography have so far found the receptor on neurons, although cultured astrocytes and glioma cells also express it. In the cortex it sits on local GABAergic interneurons and on glutamatergic pyramidal neurons, and it may also sit on cholinergic neurons of the basal forebrain. In the prefrontal cortex the receptors are mostly postsynaptic and are highly enriched on the apical dendrites of pyramidal neurons in the deep layers.2,7

PET scans of healthy volunteers have mapped the receptor in the living human brain. In the cortex its density follows the amount of its messenger RNA, in deeper regions it does not.12 In postmortem human brain, autoradiography with the antagonist M100907 showed very dense binding in all neocortical regions and only weak binding in the hippocampus. The basal ganglia and thalamus had low binding, and the cerebellum and the brainstem were virtually free of the receptor. Ketanserin and SCH 23390 displaced the radioligand, while the 5-HT1A antagonist WAY-100635 and the D2 antagonist raclopride did not.13

The receptor of rodents differs from that of humans at one position of the binding pocket. Primate and pig receptors have a serine at residue 242, rat and mouse receptors an alanine. This single change is largely responsible for marked pharmacological differences between the mouse and the human receptor, although the receptors of mammals are about 90 percent alike overall.3,7

Mice in which signalling through the receptor is disrupted show less inhibition in several tests of conflict anxiety, while their fear learning and their behaviour in tests of depression are not changed. Putting the receptor back only in the forebrain restored it mainly in layer V of the cortex and normalised the behaviour. This points to the cortex as the site of the effect.14

Psychedelics such as LSD, psilocybin and DMT are agonists at the 5-HT2A receptor, and the receptor is regarded as their primary target. Receptor occupancy in the brain relates closely to the intensity of the psychedelic effect in humans, and hallucinogenic potencies in humans and in rodent drug discrimination tests scale with the affinity for the receptor. The head-twitch response of mice, whose potencies correlate strongly with human hallucinogenic potencies, is abolished in knockout mice. A recent review reports lasting effects of psilocybin, DMT and LSD in clinical trials for major depression and substance use disorders.7,3

In a placebo-controlled study, ketanserin, which blocks 5-HT2A receptors, fully blocked the subjective effects of LSD.15 Ketanserin also blocked the effects of psilocybin, and did so in a dose-dependent way. A dose of 40 mg prevented them completely in four of five volunteers.16 Given together with mescaline, it strongly reduced the acute effects.17 Across fifteen hallucinogens, the potency in humans followed the affinity for cortical 5-HT2 binding sites.18

Blocking the receptor is a shared property of the atypical antipsychotics. Clozapine, olanzapine, quetiapine, risperidone, sertindole and ziprasidone are potent 5-HT2A antagonists and relatively weaker dopamine D2 antagonists, and at effective doses they share a low rate of extrapyramidal side effects. Meltzer put forward that a high affinity for 5-HT2A relative to D2 is what separates these atypical drugs from the typical ones.19 Trials of drugs that block only the 5-HT2A receptor gave limited evidence so far. Ritanserin, which also blocks the 5-HT2C receptor, brought little or no benefit, and M100907 showed some efficacy in one controlled study. A highly selective 5-HT2A inverse agonist, pimavanserin, has been approved for the treatment of psychosis in Parkinson's disease.19,3

Sources (19)
  1. Saltzman et al. 1991Saltzman AG, Morse B, Whitman MM, et al. (1991) Cloning of the human serotonin 5-HT2 and 5-HT1C receptor subtypes Biochem Biophys Res Commun
  2. Barnes et al. 1999Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function Neuropharmacology
  3. Cummins et al. 2025Cummins BR, Billac GB, Nichols DE, et al. (2025) 5-HT(2A) receptors: Pharmacology and functional selectivity Pharmacol Rev
  4. Kim et al. 2020Kim K, Che T, Panova O, et al. (2020) Structure of a Hallucinogen-Activated Gq-Coupled 5-HT(2A) Serotonin Receptor Cell
  5. Conn et al. 1986Conn PJ, Sanders-Bush E (1986) Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT-2 binding site J Neurosci
  6. Barnes et al. 2021Barnes NM, Ahern GP, Becamel C, et al. (2021) International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function Pharmacol Rev
  7. Kwan et al. 2022Kwan AC, Olson DE, Preller KH, et al. (2022) The neural basis of psychedelic action Nature Neuroscience
  8. Porter et al. 1999Porter RH, Benwell KR, Lamb H, et al. (1999) Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells Br J Pharmacol
  9. Pompeiano et al. 1994Pompeiano M, Palacios JM, Mengod G (1994) Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors Brain Res Mol Brain Res
  10. Jakab et al. 1998Jakab RL, Goldman-Rakic PS (1998) 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites Proc Natl Acad Sci U S A
  11. Willins et al. 1997Willins DL, Deutch AY, Roth BL (1997) Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex Synapse
  12. Beliveau et al. 2017Beliveau V, Ganz M, Feng L, et al. (2017) A High-Resolution In Vivo Atlas of the Human Brain's Serotonin System J Neurosci
  13. Hall et al. 2000Hall H, Farde L, Halldin C, et al. (2000) Autoradiographic localization of 5-HT(2A) receptors in the human brain using [(3)H]M100907 and [(11)C]M100907 Synapse
  14. Weisstaub et al. 2006Weisstaub NV, Zhou M, Lira A, et al. (2006) Cortical 5-HT <sub>2A</sub> Receptor Signaling Modulates Anxiety-Like Behaviors in Mice Science
  15. Preller et al. 2017Preller KH, Herdener M, Pokorny T, et al. (2017) The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation Curr Biol
  16. Vollenweider et al. 1998Vollenweider FX, Vollenweider-Scherpenhuyzen MF, Bäbler A, et al. (1998) Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action Neuroreport
  17. Klaiber et al. 2024Klaiber A, Schmid Y, Becker AM, et al. (2024) Acute dose-dependent effects of mescaline in a double-blind placebo-controlled study in healthy subjects Transl Psychiatry
  18. Glennon et al. 1984Glennon RA, Titeler M, McKenney JD (1984) Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents Life Sci
  19. Meltzer 1999Meltzer HY (1999) The role of serotonin in antipsychotic drug action Neuropsychopharmacology

Binding affinity (Kᵢ)

29 substances, 49 displayed values. Strongest first within each organism. The bar is pKᵢ on a log scale. Open a row to see the assay and every report behind the value.

Human

27 measurements
  • DOBAgonistdepends on assay0.60 nMNelson et al. 1999
    Assay
    cloned human 5-HT2A receptor in AV12 cells; agonist-radioligand [125I]DOI binding
    Shown value from
    Nelson et al. 1999, Table 1
    Error
    ± 0.10 SEM, n = 3

    Values depend on the assay, species or conditions, and each is valid only for its own. 2 reports in all, 0.60–23 nM.

  • DOIAgonistdepends on assayrange incl. untraced0.70 nMNelson et al. 1999 · 6 reports
    Assay
    cloned human 5-HT2A receptor in AV12 cells; agonist-radioligand [125I]DOI binding
    Shown value from
    Nelson et al. 1999, Table 1
    Range
    0.70–2500 nM in 6 reports
    Error
    ± 0.06 SEM, n = 3

    Values depend on the assay, species or conditions, and each is valid only for its own. 7 reports in all, 0.70–2500 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Nelson et al. 19990.70 nMTable 1
    Boess et al. 19941.6 nM, 38 nM, 2500 nMTable 8
    Jain et al. 202519 nMTable S4
    Glatfelter et al. 202211 nMTable 1
  • 2C-BAgonistdepends on assay0.88 nMMcLean et al. 2006
    Assay
    cloned human 5-HT2A, agonist radioligand [125I]DOI
    Shown value from
    McLean et al. 2006, Table 1 (compound 1)
    Error
    ± 0.04 SEM

    Values depend on the assay, species or conditions, and each is valid only for its own. 3 reports in all, 0.88–28 nM.

  • 2C-IAgonist3.5 nMRickli et al. 2015
    Assay
    cloned human 5-HT2A (functional FLIPR membrane potential)
    Shown value from
    Rickli et al. 2015, Table 1
    Error
    ± 1.0 SD
  • 2C-PAgonist8.1 nMRickli et al. 2015
    Assay
    cloned human 5-HT2A (functional FLIPR membrane potential)
    Shown value from
    Rickli et al. 2015, Table 1
    Error
    ± 1.0 SD
  • ETH-LADAgonist9.3 nMJain et al. 2025
    Assay
    radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
    Shown value from
    Jain et al. 2025, Table S4
  • 2C-EAgonistdepends on assay11 nMRickli et al. 2015 · 2 reports
    Assay
    cloned human receptor (HEK293)
    Shown value from
    Rickli et al. 2015, Table 1
    Range
    11–44 nM in 2 reports
    Error
    ± 1.0 SD

    Values depend on the assay, species or conditions, and each is valid only for its own. 3 reports in all, 4.5–44 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Ray 201044 nMTable S2 (AllKiData)
    Rickli et al. 201511 nMTable 1
  • 2C-CAgonist13 nMRickli et al. 2015
    Assay
    cloned human 5-HT2A (functional FLIPR membrane potential)
    Shown value from
    Rickli et al. 2015, Table 1
    Error
    ± 5.0 SD
  • LSDAgonistdepends on assay15 nMHalberstadt et al. 2020 · 9 reports
    Assay
    cloned human 5-HT2A receptor; [3H]ketanserin competition
    Shown value from
    Halberstadt et al. 2020, Table 1
    Range
    0.09–15 nM in 9 reports
    Error
    ± 4.2 SEM, n = 5

    Values depend on the assay, species or conditions, and each is valid only for its own. 11 reports in all, 0.09–15 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Halberstadt et al. 202015 nMTable 1
    Jain et al. 20258.5 nMTable S4
    Eshleman et al. 20180.09 nMTable 1
    Janowsky et al. 20140.71 nM, 0.72 nM, 0.47 nMTable 1, Table 3
    Eshleman et al. 20140.47 nMTable 2
    Eshleman et al. 20130.15 nMTable 5
    Almaula et al. 19960.38 nMTable I
  • AL-LADAgonist17 nMJain et al. 2025
    Assay
    radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
    Shown value from
    Jain et al. 2025, Table S4
  • DOMAgonistdepends on assay18 nMEshleman et al. 2018 · 7 reports
    Assay
    recombinant human 5-HT2A receptor; [125I]DOI competition binding
    Shown value from
    Eshleman et al. 2018, Table 1
    Range
    2.1–190 nM in 7 reports
    Error
    ± 1.7 SEM, n = 4

    Values depend on the assay, species or conditions, and each is valid only for its own. 8 reports in all, 2.1–507 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Luethi et al. 202666 nMTable 1
    Eshleman et al. 201818 nMTable 1
    Janowsky et al. 20144.3 nM, 2.1 nM, 14 nMTable 1, Table 3
    Jain et al. 2025190 nMTable S4
    Eshleman et al. 20148.1 nMTable 2
  • 2C-DAgonist32 nMRickli et al. 2015
    Assay
    cloned human 5-HT2A (functional FLIPR membrane potential)
    Shown value from
    Rickli et al. 2015, Table 1
    Error
    ± 5.0 SD
  • 4-HO-METAgonist46 nMKozell et al. 2023 · 3 reports
    Assay
    human 5-HT2A receptor in HEK-293 cells; [3H]5-HT competition binding
    Shown value from
    Kozell et al. 2023, Table 1
    Range
    46–177 nM in 3 reports
    Error
    ± 4.9 SEM, n = 3
    Sources and values behind the range, same assay family
    ReportValueWhere
    Rickli et al. 201657 nMTable 1
    Kozell et al. 202346 nMTable 1
    Glatfelter et al. 2023177 nMTable 2
  • 5-MeO-DMTAgonistother reports differ105 nMPuigseslloses et al. 2024 · 4 reports
    Assay
    human 5-HT2A receptor membranes; [3H]ketanserin competition binding
    Shown value from
    Puigseslloses et al. 2024, Table 1
    Range
    105–907 nM in 4 reports
    Error
    ± 22 SD

    This is the best-supported value. Other reports differ. 5 reports in all, 105–2011 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Halberstadt et al. 2012907 nMTable 1
    Puigseslloses et al. 2024105 nMTable 1
    Jain et al. 2025200 nMTable S4
    Glatfelter et al. 2024113 nMSupplement Figure S1
  • 5-MeO-MiPTAgonistother reports differ113 nMKozell et al. 2023 · 4 reports
    Assay
    human 5-HT2A receptor in HEK-293 cells; [3H]5-HT competition binding
    Shown value from
    Kozell et al. 2023, Table 1
    Range
    113–215 nM in 4 reports
    Error
    ± 31 SEM, n = 4

    This is the best-supported value. Other reports differ. 5 reports in all, 113–448 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Rickli et al. 2016163 nMTable 1
    Kozell et al. 2023113 nMTable 1
    Puigseslloses et al. 2024147 nMTable 1
    Glatfelter et al. 2024215 nMSupplement Figure S1
  • BufoteninAgonist162 nMAlmaula et al. 1996 · 2 reports
    Assay
    human 5-HT2A receptor in COS-1 cells, [3H]ketanserin competition
    Shown value from
    Almaula et al. 1996, Table I
    Range
    162–220 nM in 2 reports
    Error
    ± 14 SEM, n = 4
    Sources and values behind the range, same assay family
    ReportValueWhere
    Jain et al. 2025220 nMTable S4
    Almaula et al. 1996162 nMTable I
  • ALD-52Agonist174 nMHalberstadt et al. 2020
    Assay
    cloned human 5-HT2A receptor; [3H]ketanserin competition
    Shown value from
    Halberstadt et al. 2020, Table 1
    Error
    ± 43 SEM, n = 3
  • PsilocinAgonistunresolvedrange incl. untraced200 nMJain et al. 2025 · 4 reports
    Assay
    radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
    Shown value from
    Jain et al. 2025, Table S4
    Range
    49–200 nM in 4 reports

    Reported values disagree and no value is established. 5 reports in all, 49–340 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Rickli et al. 201649 nMTable 1
    Glatfelter et al. 2022180 nMTable 1
    Jain et al. 2025200 nMTable S4
    Dodd et al. 202349 nMTable 2
  • DMTAgonistother reports differ347 nMKozell et al. 2023 · 7 reports
    Assay
    human 5-HT2A receptor in HEK-293 cells; [3H]5-HT competition binding
    Shown value from
    Kozell et al. 2023, Table 1
    Range
    53–380 nM in 7 reports
    Error
    ± 47 SEM, n = 22

    This is the best-supported value. Other reports differ. 8 reports in all, 53–2323 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Rickli et al. 2016237 nMTable 1
    Kozell et al. 2023347 nMTable 1
    Janowsky et al. 2014210 nM, 53 nM, 175 nMTable 1, Table 3
    Jain et al. 2025380 nMTable S4
    Eshleman et al. 2014201 nMTable 2
  • 5-APBAgonist840 nMRickli et al. 2015
    Assay
    cloned human 5-HT2A receptor binding
    Shown value from
    Rickli et al. 2015, Table 3
    Error
    ± 270 SD
  • PsilocybinAgonist850 nMJain et al. 2025
    Assay
    radioligand competition binding on crude membranes of transfected HEK293T cells (secondary binding assay, radioligand not stated in the paper)
    Shown value from
    Jain et al. 2025, Table S4
  • 6-APBAgonist970 nMRickli et al. 2015
    Assay
    cloned human 5-HT2A receptor binding
    Shown value from
    Rickli et al. 2015, Table 3
    Error
    ± 230 SD
  • MDAAgonist3300 nMRickli et al. 2015
    Assay
    cloned human 5-HT2A receptor binding
    Shown value from
    Rickli et al. 2015, Table 3
    Error
    ± 800 SD
  • 4-FMA3800 nMRickli et al. 2015
    Assay
    cloned human 5-HT2A receptor binding
    Shown value from
    Rickli et al. 2015, Table 3
    Error
    ± 700 SEM
  • MescalineAgonistunresolved6300 nMRickli et al. 2015
    Assay
    cloned human receptor (HEK293)
    Shown value from
    Rickli et al. 2015, Table 1
    Error
    ± 1800 SD

    Reported values disagree and no value is established. 2 reports in all, 1900–6300 nM.

  • MDMAAgonist8300 nMEshleman et al. 2013 · 2 reports
    Assay
    cells expressing human 5-HT2A, [125I]DOI displacement
    Shown value from
    Eshleman et al. 2013, Table 5
    Range
    7800–8300 nM in 2 reports
    Error
    ± 1200 SEM, n = 4
    Sources and values behind the range, same assay family
    ReportValueWhere
    Simmler et al. 20137800 nMTable 1
    Eshleman et al. 20138300 nMTable 5
  • Mephedroneunresolved9000 nMEshleman et al. 2013 · 2 reports
    Assay
    cells expressing human 5-HT2A, [125I]DOI displacement
    Shown value from
    Eshleman et al. 2013, Table 5
    Range
    2100–9000 nM in 2 reports
    Error
    ± 1500 SEM, n = 4

    Reported values disagree and no value is established. 2 reports in all, 2100–9000 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Simmler et al. 20132100 nMTable 1
    Eshleman et al. 20139000 nMTable 5

Mouse

4 measurements
  • 5-MeO-MiPTAgonist209 nMGlatfelter et al. 2024
    Assay
    mouse brain membranes, [3H]M100907 competition binding at 5-HT2A
    Shown value from
    Glatfelter et al. 2024, Supplement Figure S12
  • 5-MeO-DMTAgonist212 nMGlatfelter et al. 2024
    Assay
    mouse brain membranes, [3H]M100907 competition binding at 5-HT2A
    Shown value from
    Glatfelter et al. 2024, Supplement Figure S12
  • PsilocinAgonist235 nMGlatfelter et al. 2022
    Assay
    C57BL/6J mouse brain membranes; [3H]M100907 displacement
    Shown value from
    Glatfelter et al. 2022, Table 2
  • PsilocybinAgonist2096 nMGlatfelter et al. 2022
    Assay
    C57BL/6J mouse brain membranes; [3H]M100907 displacement
    Shown value from
    Glatfelter et al. 2022, Table 2

Rat

9 measurements
  • 2C-BAgonistrange incl. untraced0.66 nMMcLean et al. 2006 · 2 reports
    Assay
    cloned rat 5-HT2A, agonist radioligand [125I]DOI
    Shown value from
    McLean et al. 2006, Table 1 (compound 1)
    Range
    0.66–36 nM in 2 reports
    Error
    ± 0.12 SEM
    Sources and values behind the range, same assay family
    ReportValueWhere
    McLean et al. 20060.66 nMTable 1 (compound 1)
    Halberstadt 201736 nMReview text, Structure-Activity Relationships (p. 3)
  • ETH-LADAgonistsource not traced5.1 nMPfaff et al. 1994 · 2 reports
    Assay
    rat frontal cortex homogenate; [3H]ketanserin displacement
    Shown value from
    Pfaff et al. 1994, Table 1
  • AL-LADAgonistsource not traced8.1 nMPfaff et al. 1994 · 2 reports
    Assay
    rat frontal cortex homogenate; [3H]ketanserin displacement
    Shown value from
    Pfaff et al. 1994, Table 1
    Range
    3.4–8.1 nM in 2 reports
  • PsilocinAgonistdepends on assaysource not traced25 nMDodd et al. 2023 · 2 reports
    Assay
    5-HT2A binding, compiled in a review (Table 2), original assay not restated
    Shown value from
    Dodd et al. 2023, Table 2
    Range
    6.0–25 nM in 2 reports

    Values depend on the assay, species or conditions, and each is valid only for its own. 2 reports in all, 6.0–25 nM.

  • DOMAgonistrange incl. untraced100 nMSeggel et al. 1990 · 2 reports
    Assay
    Rat frontal cortex homogenate, [3H]ketanserin binding (5-HT2 receptor, now 5-HT2A)
    Shown value from
    Seggel et al. 1990, Table I
    Sources and values behind the range, same assay family
    ReportValueWhere
    Seggel et al. 1990100 nMTable I
    Halberstadt 2017100 nMReview text, Structure-Activity Relationships (p. 3)
  • 5-MeO-DMTAgonistrange incl. untraced390 nMGlennon et al. 1984 · 4 reports
    Assay
    rat cortical membranes, [3H]ketanserin competition binding (5-HT2 sites)
    Shown value from
    Glennon et al. 1984, Table 1
    Range
    390–1200 nM in 4 reports
    Error
    ± 100 SEM
    Sources and values behind the range, same assay family
    ReportValueWhere
    Colas et al. 1997631 nMTable 1
    Glennon 19871200 nM, 390 nMTable I
    Glennon et al. 1984390 nMTable 1
  • BufoteninAgonist398 nMColas et al. 1997
    Assay
    rat 5-HT2A receptor expressed in COS-1 cells, [125I]DOI competition binding
    Shown value from
    Colas et al. 1997, Table 1
  • DMTAgonist440 nMDeliganis et al. 1991
    Assay
    Rat frontal cortex membranes, [3H]ketanserin competition without GTP (5-HT2 receptor, now 5-HT2A)
    Shown value from
    Deliganis et al. 1991, Results, Fig. 1B
    Error
    ± 20 SEM, n = 3
  • Ibogaine4800 nMSweetnam et al. 1995
    Assay
    rat cortex, [3H]ketanserin displacement
    Shown value from
    Sweetnam et al. 1995, Table 3 (Sweetnam)

Unspecified

9 measurements
  • LSDAgonistrange incl. untraced5.2 nMEgan et al. 2000 · 3 reports
    Assay
    NIH-3T3 cells stably expressing 5-HT2A, [3H]ketanserin competition (antagonist radioligand, low-affinity state KL)
    Shown value from
    Egan et al. 2000, Table I
    Range
    2.4–5.5 nM in 3 reports
    Error
    ± 0.70 SEM, n = 3
    Sources and values behind the range, same assay family
    ReportValueWhere
    Egan et al. 20005.2 nMTable I
    Glennon 19872.4 nMText, section 5 (Ergolines)
    Basargin et al. 20265.5 nMSI Table S1, p. S18
  • LSA28 nMPaulke et al. 2013
    Assay
    receptor binding assay; generic 5-HT2 label in the paper; pKi converted to Ki
    Shown value from
    Paulke et al. 2013, Table 2
  • DOIAgonist52 nMEgan et al. 2000
    Assay
    NIH-3T3 cells stably expressing 5-HT2A, [3H]ketanserin competition (antagonist radioligand, low-affinity state KL)
    Shown value from
    Egan et al. 2000, Table I
    Error
    ± 11 SEM, n = 3
  • DOBAgonistrange incl. untraced81 nMEgan et al. 2000 · 2 reports
    Assay
    NIH-3T3 cells stably expressing 5-HT2A, [3H]ketanserin competition (antagonist radioligand, low-affinity state KL)
    Shown value from
    Egan et al. 2000, Table I
    Range
    41–81 nM in 2 reports
    Error
    ± 20 SEM, n = 3
    Sources and values behind the range, same assay family
    ReportValueWhere
    Egan et al. 200081 nMTable I
    Glennon 198741 nMTable II
  • BufoteninAgonistunresolvedrange incl. untraced145 nMEgan et al. 2000 · 5 reports
    Assay
    NIH-3T3 cells stably expressing 5-HT2A, [3H]ketanserin competition (antagonist radioligand, low-affinity state KL)
    Shown value from
    Egan et al. 2000, Table I
    Range
    15–557 nM in 5 reports
    Error
    ± 8.5 SEM, n = 3

    Reported values disagree and no value is established. 5 reports in all, 15–557 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Chen et al. 2023557 nMTable 2
    Egan et al. 2000145 nMTable I
    Glennon 1987380 nM, 480 nMTable III
    Plazas et al. 202315 nMTable 5
  • DOMAgonistrange incl. untraced306 nMEgan et al. 2000 · 2 reports
    Assay
    NIH-3T3 cells stably expressing 5-HT2A, [3H]ketanserin competition (antagonist radioligand, low-affinity state KL)
    Shown value from
    Egan et al. 2000, Table I
    Range
    100–306 nM in 2 reports
    Error
    ± 56 SEM, n = 3
    Sources and values behind the range, same assay family
    ReportValueWhere
    Egan et al. 2000306 nMTable I
    Glennon 1987100 nMTable II
  • PsilocinAgonistrange incl. untraced331 nMChen et al. 2023 · 2 reports
    Assay
    5-HT2A receptor membranes (PerkinElmer ES-313-M400UA); [3H]ketanserin scintillation proximity competition binding
    Shown value from
    Chen et al. 2023, Table 2
    Range
    107–331 nM in 2 reports
    Error
    ± 96 SD, n = 3
    Sources and values behind the range, same assay family
    ReportValueWhere
    Chen et al. 2023331 nMTable 2
    Dodd et al. 2023107 nMTable 2
  • 5-MeO-DMTAgonistunresolved1325 nMEgan et al. 2000 · 2 reports
    Assay
    NIH-3T3 cells stably expressing 5-HT2A, [3H]ketanserin competition (antagonist radioligand, low-affinity state KL)
    Shown value from
    Egan et al. 2000, Table I
    Range
    113–1325 nM in 2 reports
    Error
    ± 163 SEM, n = 3

    Reported values disagree and no value is established. 2 reports in all, 113–1325 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Chen et al. 2023113 nMTable 2
    Egan et al. 20001325 nMTable I
  • DMTAgonist1513 nMChen et al. 2023 · 2 reports
    Assay
    5-HT2A receptor membranes (PerkinElmer ES-313-M400UA); [3H]ketanserin scintillation proximity competition binding
    Shown value from
    Chen et al. 2023, Table 2
    Range
    127–1513 nM in 2 reports
    Error
    ± 639 SD, n = 3
    Sources and values behind the range, same assay family
    ReportValueWhere
    Chen et al. 20231513 nMTable 2
    Keiser et al. 2009127 nMSupplementary Table 4

Functional potency (EC₅₀)

24 substances, 38 displayed values. Strongest first within each organism. Emax is shown where the paper reports it. Efficacy depends on the assay and its reference agonist.

Human

24 measurements
  • LSDAgonistother reports differ0.71 nMEshleman et al. 2018 · 2 reports
    Assay
    recombinant human 5-HT2A receptor; IP-1 formation
    Shown value from
    Eshleman et al. 2018, Table 2
    Range
    0.24–0.71 nM in 2 reports
    Error
    ± 0.07 SEM, n = 3
    Emax
    64.5 ± 6.3%

    This is the best-supported value. Other reports differ. 14 reports in all, 0.24–260 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Eshleman et al. 20180.71 nMTable 2
    Janowsky et al. 20140.24 nMTable 2
  • DOBAgonistother reports differ1.5 nMPorter et al. 1999
    Assay
    CHO-K1 cells stably expressing recombinant human 5-HT2A; FLIPR calcium mobilization
    Shown value from
    Porter et al. 1999, Table 1
    Emax
    74.0%

    This is the best-supported value. Other reports differ. 6 reports in all, 0.52–724 nM.

  • DOIAgonistother reports differ1.8 nMElmore et al. 2018 · 3 reports
    Assay
    HEK293 human 5-HT2A calcium mobilization
    Shown value from
    Elmore et al. 2018, Table 1
    Range
    0.90–2.4 nM in 3 reports
    Error
    ± 0.30 SEM
    Emax
    109.0%

    This is the best-supported value. Other reports differ. 8 reports in all, 0.42–295 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Porter et al. 19990.90 nMTable 1
    Jain et al. 20252.4 nMTable S6
    Elmore et al. 20181.8 nMTable 1
  • PsilocinAgonistother reports differ2.4 nMKlein et al. 2020 · 5 reports
    Assay
    Flp-In T-REx 293 cells expressing human 5-HT2A; Gq-mediated calcium flux
    Shown value from
    Klein et al. 2020, Table 3
    Range
    2.4–721 nM in 5 reports
    Emax
    98.4 ± 1.3%

    This is the best-supported value. Other reports differ. 12 reports in all, 2.4–5080 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Rickli et al. 2016721 nMTable 1
    Klein et al. 20202.4 nMTable 3
    Glatfelter et al. 202213 nMTable 2
    Jain et al. 20257.6 nMTable S6
    Blough et al. 201445 nMTable 2
  • BufoteninAgonistother reports differ3.5 nMBlough et al. 2014 · 2 reports
    Assay
    human 5-HT2A receptor in HEK293 cells; calcium mobilization
    Shown value from
    Blough et al. 2014, Table 1
    Range
    3.5–4.8 nM in 2 reports
    Error
    ± 0.08 SEM, n = 3
    Emax
    100.0 ± 2.0%

    This is the best-supported value. Other reports differ. 4 reports in all, 3.5–1730 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Jain et al. 20254.8 nMTable S6
    Blough et al. 20143.5 nMTable 1
  • 4-HO-METAgonistother reports differ4.0 nMKlein et al. 2020 · 3 reports
    Assay
    Flp-In T-REx 293 cells expressing human 5-HT2A; Gq-mediated calcium flux
    Shown value from
    Klein et al. 2020, Table 3
    Range
    4.0–37 nM in 3 reports
    Emax
    96.8 ± 1.1%

    This is the best-supported value. Other reports differ. 4 reports in all, 4.0–87 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Rickli et al. 201637 nMTable 1
    Klein et al. 20204.0 nMTable 3
    Glatfelter et al. 202318 nMTable S1 (Supporting Information)
  • 2C-IAgonistdepends on assay5.9 nMPottie et al. 2020
    Assay
    stable HEK293 5-HT2A–β-arrestin2 recruitment
    Shown value from
    Pottie et al. 2020, Table 2
    Emax
    70.6%

    Values depend on the assay, species or conditions, and each is valid only for its own. 7 reports in all, 4.0–510 nM.

  • 2C-EAgonistdepends on assay6.9 nMPottie et al. 2020
    Assay
    stable HEK293 5-HT2A–β-arrestin2 recruitment
    Shown value from
    Pottie et al. 2020, Table 2
    Emax
    83.5%

    Values depend on the assay, species or conditions, and each is valid only for its own. 7 reports in all, 2.5–110 nM.

  • AL-LADAgonist8.3 nMJain et al. 2025
    Assay
    5-HT2A receptor, calcium flux (FLIPR Tetra) in tetracycline-inducible Flp-In T-REx 293 cells
    Shown value from
    Jain et al. 2025, Table S6
  • 5-MeO-DMTAgonistother reports differ8.9 nMGlatfelter et al. 2024 · 4 reports
    Assay
    Transfected cells expressing human 5-HT2A; Galpha-q dissociation BRET
    Shown value from
    Glatfelter et al. 2024, Figure 2A-B
    Range
    8.9–183 nM in 4 reports
    Emax
    95.3%

    This is the best-supported value. Other reports differ. 13 reports in all, 1.9–385 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Glatfelter et al. 20248.9 nMFigure 2A-B
    Ray 201050 nM, 57 nM, 183 nMTable S3
  • 2C-BAgonistdepends on assay9.0 nMPottie et al. 2020
    Assay
    stable HEK293 5-HT2A–β-arrestin2 recruitment
    Shown value from
    Pottie et al. 2020, Table 2
    Emax
    89.0%

    Values depend on the assay, species or conditions, and each is valid only for its own. 4 reports in all, 1.9–80 nM.

  • ETH-LADAgonist9.3 nMJain et al. 2025
    Assay
    5-HT2A receptor, calcium flux (FLIPR Tetra) in tetracycline-inducible Flp-In T-REx 293 cells
    Shown value from
    Jain et al. 2025, Table S6
    Emax
    94.5 ± 1.5%
  • 5-MeO-MiPTAgonistother reports differ17 nMGlatfelter et al. 2024 · 3 reports
    Assay
    Transfected cells expressing human 5-HT2A; Galpha-q dissociation BRET
    Shown value from
    Glatfelter et al. 2024, Figure 2A-B
    Range
    17–285 nM in 3 reports
    Emax
    94.8%

    This is the best-supported value. Other reports differ. 11 reports in all, 5.9–566 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Glatfelter et al. 202417 nMFigure 2A-B
    Ray 201020 nM, 285 nMTable S3
  • 2C-CAgonistdepends on assay19 nMPottie et al. 2020
    Assay
    stable HEK293 5-HT2A–β-arrestin2 recruitment
    Shown value from
    Pottie et al. 2020, Table 2
    Emax
    91.2%

    Values depend on the assay, species or conditions, and each is valid only for its own. 5 reports in all, 4.6–200 nM.

  • ALD-52Agonist38 nMHalberstadt et al. 2020
    Assay
    Flp-In T-REx 293 cells expressing human 5-HT2A; Gq calcium mobilization
    Shown value from
    Halberstadt et al. 2020, Table 4
    Emax
    25.0 ± 2.0%
  • DOMAgonistother reports differ40 nMEshleman et al. 2018 · 3 reports
    Assay
    recombinant human 5-HT2A receptor; IP-1 formation
    Shown value from
    Eshleman et al. 2018, Table 2
    Range
    21–40 nM in 3 reports
    Error
    ± 5.4 SEM, n = 3
    Emax
    94.6 ± 4.1%

    This is the best-supported value. Other reports differ. 14 reports in all, 2.4–1698 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Luethi et al. 202621 nMTable 1
    Eshleman et al. 201840 nMTable 2
    Janowsky et al. 201425 nMTable 2
  • 2C-DAgonistdepends on assay44 nMPottie et al. 2020 · 2 reports
    Assay
    stable HEK293 5-HT2A–β-arrestin2 recruitment
    Shown value from
    Pottie et al. 2020, Table 2
    Range
    16–44 nM in 2 reports
    Emax
    78.7%

    Values depend on the assay, species or conditions, and each is valid only for its own. 8 reports in all, 16–8100 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Pottie et al. 202044 nMTable 2
    Pottie et al. 202316 nMTable 1
  • 2C-PAgonist90 nMRickli et al. 2015
    Assay
    cloned human 5-HT2A (functional FLIPR membrane potential)
    Shown value from
    Rickli et al. 2015, Table 1
    Error
    ± 60 SD
    Emax
    63.0 ± 5.0%
  • DMTAgonistunresolvedrange incl. untraced527 nMKozell et al. 2023 · 3 reports
    Assay
    human 5-HT2A receptor in HEK-293 cells; IP-1 formation (Cisbio kit)
    Shown value from
    Kozell et al. 2023, Table 1
    Range
    227–527 nM in 3 reports
    Error
    ± 45 SEM, n = 20
    Emax
    38.4 ± 1.8%

    Reported values disagree and no value is established. 14 reports in all, 38–871 nM.

    Sources and values behind the range, same assay family
    ReportValueWhere
    Kozell et al. 2023527 nMTable 1
    Janowsky et al. 2014227 nMTable 2
    Cameron et al. 2018269 nMTable 2
  • MDAAgonist630 nMRickli et al. 2015
    Assay
    cloned human 5-HT2A receptor, functional activation
    Shown value from
    Rickli et al. 2015, Table 3
    Error
    ± 240 SD
    Emax
    77.0 ± 16.0%
  • PsilocybinAgonistdepends on assay1242 nMGlatfelter et al. 2022
    Assay
    cells expressing human 5-HT2A; beta-arrestin 2 recruitment
    Shown value from
    Glatfelter et al. 2022, Table 2
    Emax
    74.0%

    Values depend on the assay, species or conditions, and each is valid only for its own. 4 reports in all, 1242–4900 nM.

  • MDMAAgonist5200 nMJain et al. 2025
    Assay
    5-HT2A receptor, calcium flux (FLIPR Tetra) in tetracycline-inducible Flp-In T-REx 293 cells
    Shown value from
    Jain et al. 2025, Table S6
    Emax
    46.9 ± 2.3%
  • 6-APBAgonist5900 nMRickli et al. 2015
    Assay
    cloned human 5-HT2A receptor, functional activation
    Shown value from
    Rickli et al. 2015, Table 3
    Error
    ± 1800 SD
    Emax
    43.0 ± 23.0%
  • 5-APBAgonist6300 nMRickli et al. 2015
    Assay
    cloned human 5-HT2A receptor, functional activation
    Shown value from
    Rickli et al. 2015, Table 3
    Error
    ± 2100 SD
    Emax
    54.0 ± 35.0%

Mouse

6 measurements
  • 4-HO-METAgonist2.5 nMKlein et al. 2020
    Assay
    Flp-In T-REx 293 cells expressing mouse 5-HT2A; Gq-mediated calcium flux
    Shown value from
    Klein et al. 2020, Table 3
    Emax
    98.2 ± 1.2%
  • PsilocinAgonist3.2 nMKlein et al. 2020
    Assay
    Flp-In T-REx 293 cells expressing mouse 5-HT2A; Gq-mediated calcium flux
    Shown value from
    Klein et al. 2020, Table 3
    Emax
    95.7 ± 1.0%
  • LSDAgonist4.3 nMHalberstadt et al. 2020
    Assay
    Flp-In T-REx 293 cells expressing mouse 5-HT2A; Gq calcium mobilization
    Shown value from
    Halberstadt et al. 2020, Table 4
    Emax
    86.0 ± 3.0%
  • ALD-52Agonist12 nMHalberstadt et al. 2020
    Assay
    Flp-In T-REx 293 cells expressing mouse 5-HT2A; Gq calcium mobilization
    Shown value from
    Halberstadt et al. 2020, Table 4
    Emax
    29.0 ± 1.0%
  • 5-MeO-DMTAgonist48 nMGlatfelter et al. 2024
    Assay
    Transfected cells expressing mouse 5-HT2A; Galpha-q dissociation BRET
    Shown value from
    Glatfelter et al. 2024, Figure 2A-B
    Emax
    91.6%
  • 5-MeO-MiPTAgonist50 nMGlatfelter et al. 2024
    Assay
    Transfected cells expressing mouse 5-HT2A; Galpha-q dissociation BRET
    Shown value from
    Glatfelter et al. 2024, Figure 2A-B
    Emax
    96.4%

Rat

7 measurements
  • 2C-IAgonist26 nMAcuña-Castillo et al. 2002
    Assay
    rat 5-HT2A receptor in Xenopus laevis oocytes; two-electrode voltage clamp (Cl- current)
    Shown value from
    Acuña-Castillo et al. 2002, Table 3
    Error
    ± 6.0 SEM, n = 6
    Emax
    17.0 ± 4.0%
  • DOMAgonist29 nMAcuña-Castillo et al. 2002
    Assay
    rat 5-HT2A receptor in Xenopus laevis oocytes; two-electrode voltage clamp (Cl- current)
    Shown value from
    Acuña-Castillo et al. 2002, Table 3
    Error
    ± 9.0 SEM, n = 6
    Emax
    44.0 ± 11.0%
  • DOBAgonist50 nMAcuña-Castillo et al. 2002
    Assay
    rat 5-HT2A receptor in Xenopus laevis oocytes; two-electrode voltage clamp (Cl- current)
    Shown value from
    Acuña-Castillo et al. 2002, Table 3
    Error
    ± 15 SEM, n = 7
    Emax
    57.0 ± 11.0%
  • DOIAgonist57 nMAcuña-Castillo et al. 2002
    Assay
    rat 5-HT2A receptor in Xenopus laevis oocytes; two-electrode voltage clamp (Cl- current)
    Shown value from
    Acuña-Castillo et al. 2002, Table 3
    Error
    ± 24 SEM, n = 6
    Emax
    46.0 ± 9.0%
  • 2C-DAgonist586 nMAcuña-Castillo et al. 2002
    Assay
    rat 5-HT2A receptor in Xenopus laevis oocytes; two-electrode voltage clamp (Cl- current)
    Shown value from
    Acuña-Castillo et al. 2002, Table 3
    Error
    ± 312 SEM, n = 5
    Emax
    6.0 ± 3.0%
  • 2C-BAgonistdepends on assay689 nMAcuña-Castillo et al. 2002
    Assay
    rat 5-HT2A receptor in Xenopus laevis oocytes; two-electrode voltage clamp (Cl- current)
    Shown value from
    Acuña-Castillo et al. 2002, Table 3
    Error
    ± 179 SEM, n = 4
    Emax
    4.0 ± 2.0%

    Values depend on the assay, species or conditions, and each is valid only for its own. 2 reports in all, 27–689 nM.

  • DMTAgonist3000 nMDeliganis et al. 1991
    Assay
    Rat cortical slices, phosphoinositide turnover (5-HT2 receptor, now 5-HT2A)
    Shown value from
    Deliganis et al. 1991, Results, Fig. 3
    Emax
    20.0%

Unspecified

1 measurement
  • DMTAgonistrange incl. untraced983 nMSmith et al. 1998 · 2 reports
    Assay
    NIH 3T3 fibroblasts expressing the 5-HT2A receptor, [3H]inositol phosphate formation
    Shown value from
    Smith et al. 1998, Results, Fig. 1
    Emax
    90.0%
    Sources and values behind the range, same assay family
    ReportValueWhere
    Cameron et al. 2018983 nMTable 2
    Smith et al. 1998983 nMResults, Fig. 1

Also reported to act here

Substances reported to act here, without a displayed value.

Values are published numbers in nM per organism. Different assays, species and receptor preparations are not directly interchangeable, and a value does not establish clinical potency or safety.